{"id":"https://openalex.org/A5110047899","orcid":null,"observed_orcids":[],"display_name":"Thomas Brodie","raw_author_names":["T. Brodie","Thomas Brodie"],"full_name":"Thomas Brodie","works_count":8,"cited_by_count":87,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":6,"i10_index":5},"ids":{"openalex":"https://openalex.org/A5110047899","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I188950975","ror":"https://ror.org/01xsqw823","display_name":"GlaxoSmithKline (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]},"years":[2008]},{"institution":{"id":"https://openalex.org/I4210091812","ror":"https://ror.org/00gtmwv55","display_name":"Bristol-Myers Squibb (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},"years":[2020,2018,2017,2014]},{"institution":{"id":"https://openalex.org/I4210114143","ror":"https://ror.org/025vn3989","display_name":"GlaxoSmithKline (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]},"years":[2002]}],"last_known_institutions":[{"id":"https://openalex.org/I4210091812","ror":"https://ror.org/00gtmwv55","display_name":"Bristol-Myers Squibb (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"topics":[{"id":"https://openalex.org/T10686","display_name":"Effects and risks of endocrine disrupting chemicals","count":2,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","count":2,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10105","display_name":"Osteoarthritis Treatment and Mechanisms","count":1,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","count":1,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11869","display_name":"Per- and polyfluoroalkyl substances research","value":1.56e-05,"subfield":{"id":"https://openalex.org/subfields/2304","display_name":"Environmental Chemistry"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":1.13e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10686","display_name":"Effects and risks of endocrine disrupting chemicals","value":1.12e-05,"subfield":{"id":"https://openalex.org/subfields/2307","display_name":"Health, Toxicology and Mutagenesis"},"field":{"id":"https://openalex.org/fields/23","display_name":"Environmental Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","value":1.07e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","value":1.06e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.7788047790527344},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.5352773070335388},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.472202867269516},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.4323299527168274},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.40367406606674194}],"counts_by_year":[{"year":2002,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2008,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":1},{"year":2014,"works_count":2,"oa_works_count":0,"cited_by_count":2},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":9},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2017,"works_count":1,"oa_works_count":0,"cited_by_count":2},{"year":2018,"works_count":2,"oa_works_count":0,"cited_by_count":3},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":2},{"year":2020,"works_count":1,"oa_works_count":0,"cited_by_count":9},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":10},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":3},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":7},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":6},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":2}],"display_name_alternatives":["T. Brodie","Thomas Brodie"],"block_key":"t brodie","works_api_url":"https://api.openalex.org/works?filter=author.id:A5110047899","updated_date":"2026-10-27T12:30:23","created_date":"2016-06-24T00:00:00"}